Cargando…

Evaluation of circulating plasma proteins in breast cancer using Mendelian randomisation

Biomarkers for early detection of breast cancer may complement population screening approaches to enable earlier and more precise treatment. The blood proteome is an important source for biomarker discovery but so far, few proteins have been identified with breast cancer risk. Here, we measure 2929...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mälarstig, Anders, Grassmann, Felix, Dahl, Leo, Dimitriou, Marios, McLeod, Dianna, Gabrielson, Marike, Smith-Byrne, Karl, Thomas, Cecilia E., Huang, Tzu-Hsuan, Forsberg, Simon K. G., Eriksson, Per, Ulfstedt, Mikael, Johansson, Mattias, Sokolov, Aleksandr V., Schiöth, Helgi B., Hall, Per, Schwenk, Jochen M., Czene, Kamila, Hedman, Åsa K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10667261/ https://www.ncbi.nlm.nih.gov/pubmed/37996402 http://dx.doi.org/10.1038/s41467-023-43485-8

Ejemplares similares

Circulating proteins reveal prior use of menopausal hormonal therapy and increased risk of breast cancer
por: Thomas, Cecilia E., et al.
Publicado: (2022)

Interval breast cancer is associated with other types of tumors
por: Grassmann, Felix, et al.
Publicado: (2019)

Identifying proteomic risk factors for overall, aggressive and early onset prostate cancer using Mendelian randomization and tumor spatial transcriptomics
por: Desai, Trishna A, et al.
Publicado: (2023)

Cohort Profile: The Karolinska Mammography Project for Risk Prediction of Breast Cancer (KARMA)
por: Gabrielson, Marike, et al.
Publicado: (2017)

Affinity proteomic profiling of plasma for proteins associated to area-based mammographic breast density
por: Byström, Sanna, et al.
Publicado: (2018)

Association of reproductive history with breast tissue characteristics and receptor status in the normal breast
por: Gabrielson, Marike, et al.
Publicado: (2018)

Determinants of Mammographic Density Change
por: Azam, Shadi, et al.
Publicado: (2019)

Topical Endoxifen for Mammographic Density Reduction—A Randomized Controlled Trial
por: Bäcklund, Magnus, et al.
Publicado: (2022)

Predictors of mammographic microcalcifications
por: Azam, Shadi, et al.
Publicado: (2020)

Mammographic microcalcifications and risk of breast cancer
por: Azam, Shadi, et al.
Publicado: (2021)

Time to Mammographic Density Decrease After Exposure to Tamoxifen
por: Bäcklund, Magnus, et al.
Publicado: (2022)

Inclusion of Plasma Prolactin Levels in Current Risk Prediction Models of Premenopausal and Postmenopausal Breast Cancer
por: Gabrielson, Marike, et al.
Publicado: (2018)

Hormonal determinants of mammographic density and density change
por: Gabrielson, Marike, et al.
Publicado: (2020)

Neoantigen Vaccines; Clinical Trials, Classes, Indications, Adjuvants and Combinatorial Treatments
por: Niemi, Jenni Viivi Linnea, et al.
Publicado: (2022)

Side effects of low-dose tamoxifen: results from a six-armed randomised controlled trial in healthy women
por: Hammarström, Mattias, et al.
Publicado: (2023)

Hyperthyroidism is associated with breast cancer risk and mammographic and genetic risk predictors
por: Yang, Haomin, et al.
Publicado: (2020)

Mammographic features are associated with cardiometabolic disease risk and mortality
por: Grassmann, Felix, et al.
Publicado: (2021)

Evidence of a Causal Link Between the Well-Being Spectrum and the Risk of Myocardial Infarction: A Mendelian Randomization Study
por: Rukh, Gull, et al.
Publicado: (2022)

A systems genomics approach to uncover the molecular properties of cancer genes
por: Grassmann, Felix, et al.
Publicado: (2020)

CYP2D6 Genotype Predicts Tamoxifen Discontinuation and Prognosis in Patients With Breast Cancer
por: He, Wei, et al.
Publicado: (2020)

Low-Dose Tamoxifen for Mammographic Density Reduction: A Randomized Controlled Trial
por: Eriksson, Mikael, et al.
Publicado: (2021)

Treatment of ADHD: Drugs, psychological therapies, devices, complementary and alternative methods as well as the trends in clinical trials
por: Nazarova, Victoria A., et al.
Publicado: (2022)

Nanoparticles in Clinical Trials: Analysis of Clinical Trials, FDA Approvals and Use for COVID-19 Vaccines
por: Namiot, Eugenia D., et al.
Publicado: (2023)

Prediction of breast cancer risk for sisters of women attending screening
por: Mao, Xinhe, et al.
Publicado: (2023)

The international clinical trials registry platform (ICTRP): data integrity and the trends in clinical trials, diseases, and drugs
por: Namiot, Eugenia D., et al.
Publicado: (2023)

Methylation in MAD1L1 is associated with the severity of suicide attempt and phenotypes of depression
por: Sokolov, Aleksandr V., et al.
Publicado: (2023)

Personality, lifestyle and job satisfaction: causal association between neuroticism and job satisfaction using Mendelian randomisation in the UK biobank cohort
por: Rukh, Gull, et al.
Publicado: (2020)

Correction to: Deciphering the genetic and epidemiological landscape of mitochondrial DNA abundance
por: Hägg, Sara, et al.
Publicado: (2021)

Deciphering the genetic and epidemiological landscape of mitochondrial DNA abundance
por: Hägg, Sara, et al.
Publicado: (2020)

A constant risk for familial breast cancer? A population-based family study
por: Czene, Kamila, et al.
Publicado: (2009)

Breast cancer tumour growth modelling for studying the association of body size with tumour growth rate and symptomatic detection using case-control data
por: Abrahamsson, Linda, et al.
Publicado: (2015)

Studying the association between longitudinal mammographic density measurements and breast cancer risk: a joint modelling approach
por: Illipse, Maya, et al.
Publicado: (2023)

Differentiation of two human neuroblastoma cell lines alters SV2 expression patterns
por: Lekholm, Emilia, et al.
Publicado: (2021)

Association between breast cancer risk and disease aggressiveness: Characterizing underlying gene expression patterns
por: Ugalde‐Morales, Emilio, et al.
Publicado: (2020)

Association of Microcalcification Clusters with Short-term Invasive Breast Cancer Risk and Breast Cancer Risk Factors
por: Alsheh Ali, Maya, et al.
Publicado: (2019)

Use of Low-Dose Tamoxifen to Increase Mammographic Screening Sensitivity in Premenopausal Women
por: Eriksson, Mikael, et al.
Publicado: (2021)

Risk of heart disease following treatment for breast cancer – results from a population-based cohort study
por: Yang, Haomin, et al.
Publicado: (2022)

Risk of estrogen receptor–specific breast cancer by family history of estrogen receptor subtypes and other cancers
por: Wang, Qiao-Li, et al.
Publicado: (2023)

Is Genetic Background Important in Lung Cancer Survival?
por: Lindström, Linda S., et al.
Publicado: (2009)

The influence of menstrual risk factors on tumor characteristics and survival in postmenopausal breast cancer
por: Orgéas, Chantal C, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_r28fjjj79chp4lc78v25ffp91c